Follow ASTCT®
Continuing Medical and Professional Education: 2026 Tandem Meetings | Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR are sponsored by the Medical College of Wisconsin.
ACCME Accreditation Statement: The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.
AMA Credit Designation: The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Featured
Non-Featured
ChARTing New Ground NHL: Insights on Practice-changing Evidence, Real-World Experience and Outpatient Delivery
Ballroom J
This activity is supported through educational grants from Bristol Myers Squibb, Caribou Biosciences, Inc., Kite, A Gilead Company, Miltenyi Biomedicine Inc., and Novartis Pharmaceuticals Corporation.
Optimizing Transplant Outcomes Through Contemporary CMV Management: Strategies to Address Clinical Challenges in Treatment of Refractory or Resistant Disease
Ballroom J
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Personalizing Allo-HSCT: Evolving Towards RTC Without Compromise
Ballroom J
Supported by an independent educational grant from Medexus Pharmaceuticals Inc.
Adapting to Innovation in B-Cell Cancers: Advances With Targeted Therapy & CAR-T and Revisiting the Role of Transplant
Ballroom I
This activity is supported through independent educational grants from AstraZeneca and Bristol Myers Squibb.
Transformative Care for Hemoglobinopathies: Guidance on the Gene Therapy Experience in SCD & Thalassemia
Ballroom J
This activity is supported by educational grants from Beam Therapeutics and Vertex Pharmaceuticals.
Sorting the Sequence in Multiple Myeloma: Personalized Choices With BCMA and Non-BCMA Immunotherapies in Relapsed/Refractory Disease
Ballroom I
This activity is supported by independent educational grants from Arcellx, Inc. and Kite, a Gilead Company; AstraZeneca; Johnson & Johnson; and Legend Biotech.
Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD
Ballroom J
This activity is supported by an educational grant from Incyte Corporation.